227 results on '"Horgan, Constance"'
Search Results
2. Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application
3. Mobile clinics for opioid use disorders: What they do and how they do it. A qualitative analysis
4. Development of an addiction recovery patient-reported outcome measure: Response to Addiction Recovery (R2AR)
5. The role of health plans in addressing the opioid crisis: A qualitative study
6. Payment and Financing for Substance Use Screening and Brief Intervention for Adolescents and Adults in Health, School, and Community Settings
7. Impact of recovery support navigators on continuity of care after detoxification
8. Is it feasible to pay specialty substance use disorder treatment programs based on patient outcomes?
9. Incentives in a public addiction treatment system: Effects on waiting time and selection
10. Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification
11. Evaluating the feasibility and impact of case rate payment for recovery support navigator services: a mixed methods study
12. Influencing quality of outpatient SUD care: Implementation of alerts and incentives in Washington State
13. Design and impact of bundled payment for detox and follow-up care
14. Quality Measurement and Accountability for Substance Abuse and Mental Health Services in Managed Care Organizations
15. Implementation of Client Incentives within a Recovery Navigation Program
16. Referral to Treatment After Positive Screens for Unhealthy Drug Use in an Outpatient Veterans Administration Setting
17. Access to Addiction Pharmacotherapy in Private Health Plans
18. Management of Newer Medications for Attention-Deficit/Hyperactivity Disorder in Commercial Health Plans
19. A performance measure for continuity of care after detoxification: Relationship with outcomes
20. Criminal justice outcomes after engagement in outpatient substance abuse treatment
21. Prescribing Medications for Alcohol Use Disorder: A Qualitative Study of Primary Care Physician Decision Making.
22. Establishing the feasibility of measuring performance in use of addiction pharmacotherapy
23. Performance contracting and quality improvement in outpatient treatment: Effects on waiting time and length of stay
24. Lessons from five states: Public sector use of the Washington Circle performance measures
25. Advancing performance measures for use of medications in substance abuse treatment
26. Identification and Treatment of Mental and Substance Use Conditions: Health Plans Strategies
27. Engagement in Outpatient Substance Abuse Treatment and Employment Outcomes
28. Race/Ethnicity and Quality Indicators for Outpatient Treatment for Substance Use Disorders
29. Adapting Washington Circle performance measures for public sector substance abuse treatment systems
30. Treatment Cost Analysis Tool (TCAT) for estimating costs of outpatient treatment services
31. Bringing Excluded Psychiatric Facilites under the Medicare Prospective Payment System: A Review of Research Evidence and Policy Options
32. Drinking Patterns of Older Adults with Chronic Medical Conditions
33. Randomized Trial of Enhanced Profiling in Substance Abuse Treatment
34. Availability of addiction medications in private health plans
35. Health services and financing of treatment
36. Integrated Employee Assistance Program/Managed Behavioral Health Care Benefits: Relationship with Access and Client Characteristics
37. Accessing Specialty Behavioral Health Treatment in Private Health Plans
38. Benefit Limits for Behavioral Health Care in Private Health Plans
39. Changes in How Health Plans Provide Behavioral Health Services
40. Unhealthy Drinking Patterns and Receipt of Preventive Medical Services by Older Adults
41. Changing Mental Health Gatekeeping: Effects on Performance Indicators
42. Hispanics in specialty treatment for substance use disorders
43. Health Plan Requirements for Mental Health and Substance Use Screening in Primary Care
44. Are Washington Circle performance measures associated with decreased criminal activity following treatment?
45. Management of access to branded psychotropic medications in private health plans
46. Report of Recommendations: The Annapolis Coalition Conference on Behavioral Health Work Force Competencies
47. Performance measures for alcohol and other drug services
48. Incentive effects on cooperation rates and sample composition in the alcohol and drug services study
49. Why carve out? Determinants of behavioral health contracting choice among large U.S. employers
50. Establishing the feasibility of performance measures for alcohol and other drugs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.